Pseudomonas

ATS, IDSA revamp pneumonia testing guidance
By LabPulse.com staff writers
The new recommendations apply to the diagnosis and treatment of community-acquired pneumonia, from the time of signs and symptoms through treatment with antibiotics and follow-up chest imaging. They were published by a multidisciplinary team, including Dr. Joshua Metlay, PhD, chief of internal medicine at Massachusetts General Hospital (American Journal of Respiratory and Critical Care Medicine, October 1, 2019, Vol. 200:7, pp. e45-e65).
October 2, 2019
2019 05 13 20 10 9004 Staphylococcus Aureus Bacteria 400
Accelerate's PhenoTest BC kit gets CE Mark
By LabPulse.com staff writers
The new kit allows antimicrobial testing for the combination treatments ceftazidime-avibactam and ceftolozane-tazobactam for Enterobacteriaceae and Pseudomonas aeruginosa bacteria and trimethoprim-sulfamethoxazole for Acinetobacter baumannii.
August 1, 2019
2019 05 16 20 57 4949 Carbapenem Resistant Enterobacteriaceae 400
T2Bacteria panel proves itself, but will hospitals buy in?
By Emily Hayes
The prospective study of 1,427 patients in 11 centers tested the sensitivity, specificity, and speed of the T2Bacteria panel, which is an insert for T2 Biosystems' T2Dx miniaturized magnetic resonance instrument. The system directly tests blood for five types of bacteria ("ESKAPE pathogens") that cause bloodstream infections (BSI): Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Escherichia coli.
May 13, 2019
2019 05 13 20 10 9004 Staphylococcus Aureus Bacteria 400
Page 1 of 1